GASTROENTEROPANCREATICO TUMORS

Clinical trials for GASTROENTEROPANCREATICO TUMORS explained in plain language.

Never miss a new study

Get alerted when new GASTROENTEROPANCREATICO TUMORS trials appear

Sign up with your email to follow new studies for GASTROENTEROPANCREATICO TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Radioactive drug combo aims to zap rare gut tumors

Disease control Recruiting now

This study is testing whether combining two drugs, Lutathera and Olaparib, can shrink rare neuroendocrine tumors in the digestive system or pancreas that cannot be removed by surgery. About 56 adults will receive Lutathera through an IV every 8 weeks and take Olaparib pills twice…

Matched conditions: GASTROENTEROPANCREATICO TUMORS

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

GASTROENTEROPANCREATICO TUMORS

Get alerted when new GASTROENTEROPANCREATICO TUMORS trials appear

Radioactive drug combo aims to zap rare gut tumors